Latest Lead News

US Masters Residential Property Group has announced a special distribution of 10 cents per stapled security, payable in early August 2025. Investors should note key dates for eligibility and payment.

Brightstar Resources has reported significant high-grade gold assay results from its extensive drilling campaign at the Sandstone Hub in Western Australia, highlighting promising early-stage prospects and reinforcing the project’s growth potential.

JPMorgan Asset Management (Australia) Limited has announced the final cash distributions and reinvestment prices for several of its active ETFs for the financial year ended 30 June 2025, with payments scheduled for mid-July.

Yojee Limited has successfully raised $5.4 million through an oversubscribed placement, fueling development of its MOSAIC freight forwarding platform and expansion across the Asia Pacific region.

SportsHero Limited has inked major partnerships with leading Southeast Asian telcos, including a US$1 million contract with the Philippines’ PLDT, to expand its cloud-based gaming platform across the region.

QEM Limited has completed its leadership transition with Robert Cooper stepping in as Managing Director and CEO, signaling a strategic shift as the company advances its flagship Julia Creek Vanadium and Energy Project.

Domino’s Pizza Enterprises announces CEO Mark Dyck will step down by December 2025, with Chairman Jack Cowin stepping in as interim Executive Chair to guide the company through its next growth phase.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Battery Age Minerals has successfully raised $3 million to fund maiden drilling at its Bleiberg Germanium-Zinc Project in Austria and advance exploration at the El Aguila Gold-Silver Project in Argentina, attracting new investors and reinforcing its strategic position in critical minerals.

St George Mining has launched advanced geophysical surveys at its Araxá Niobium and Rare Earths Project in Brazil, aiming to pinpoint new high-grade mineralisation zones and support ongoing drilling efforts.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.